Dr. Nikhil’s primary interest lies in lung and gastrointestinal malignancies, and he has been part of many clinical research projects.
He has excellent communication and presentation skills and has been invited as a speaker in numerous national and international conferences.
Dr. Nikhil has handled more than 60000 cases so far.
Dr. Nikhil is a member of the European Society of Medical Oncology.
He was awarded at the Indian Society of Neuro-Oncology Conference 2017- Best Poster Presentation Award.
He was awarded at the Lung Cancer Consortium Asia 2017 – Best Poster Presentation Award.
He was awarded at the Lung Cancer Consortium Asia 2017 – Best Trial in Progress Award.
Dr. Nikhil has over 25 publications in International Journals and is well-known in academic circles.
Simultaneous occurrence of internal capsule infarct and cerebellar haemorrhage in a patient with hemiplegia. BMJ Case Rep. 2014 Jan.
Isolated bilateral upper lobar anomalous pulmonary venous connection–a rare anomaly confirmed on CT imaging. BMJ Case Rep. 2012 May.
Second-Line Palliative Chemotherapy in Advanced Gallbladder Cancer, CAP-IRI: Safe and Effective Option. J Gastrointest Cancer. 2016 May 23.
Pazopanib in metastatic multiply treated progressive gastrointestinal stromal tumours: feasible and efficacious. Gastrointest Oncol. 2016 Aug;7(4):638-43.
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer. Does exon 19 deletion differ from exon 21 mutation? – 24February 2018
Radiation-Induced -Neuropsychiatric manifestation in a Patient with Brain Metastasis; A Diagnostic & Therapeutic challenge for Consultation – Liaison Psychiatrist. – 25 September 2021
Distress Management in Patients with Head & Neck Cancer Before start of Palliative Chemotherapy – A practical approach. – 4 September 2021.
Resection of Isolated Port site Metastasis in Gall bladder Cancers - careful selection and Perioperative systemic therapy may improve outcome. 9 September 2018.
Impact of exon 19 versus exon 21 EGFR – activating mutation in outcomes with upfront pemetrexed – carboplatin chemotherapy. – 24 October 2017
Randomised phase 3 open label study of quality of life of Patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non-EGFR mutated non-small cell lung cancer. – 29 October 2019.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.